Pricing Sign in

Role
Country
Date of registration
Address

Made In Tracker

Made In Tracker EasyUDI

Legal

Privacy Policy Legal Notice

About

About FAQ Contact

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

Organization name
UDI-DI code
Reference / catalog number

Transjugal — Class I MDR by adapsia

MD Atlas
adapsia

EUDAMED last updated this device on Apr 8, 2026

Transjugal

36639173400SJ

On the marketClass I

Applicable legislation: MDR [Regulation (EU) 2017/745 on medical devices]
Organization name: adapsia
UDI-DI code: 03663917008582
Reference / catalog number: 230-350

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Email

Password

No account yet?

Manufacturer information

Organization name: adapsia
SRN: FR-MF-000011356
Manufacturer status: Active

Related devices

Adaptation instrument36639173310SGOn the market Plate pusher36639173320SKOn the market Plate pusher for high osteotomy36639173320SKOn the market Plier on-site adjustment 2 in 136639173100S3On the market Pliers on-site adjustment shortening36639173100S3On the market

Certificates

No certificates registered for this manufacturer.

No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.

Critical warnings

1 warning recorded — scroll inside the panel to see all entries.

CW999
Do not use on a patient with: • Infection (known or suspected) of the implantation area or surrounding area • Allergy or hypersensitivity to materials (see Materials section) • Bone structure too weak and/or bone density too low to support constraints transferred by the implant • Fluorination treatment • Irradiation treatment For patients with absolute or relative metabolic contraindication (diabetes, significant consumption of tobacco or alcohol, pregnancy, etc.) the choice of installation of the implant is made on a per case basis, with the utmost caution, by qualified persons who are fully responsible for this choice.

Market distribution

Primary placement in France; available across 1 country total.

Country	On market since	Until
FrancePrimary placement	Feb 8, 2024	Still on market

Device identification

Trade name: Transjugal
UDI-DI code: 03663917008582
Basic UDI-DI: 36639173400SJ
Reference / catalog number: 230-350
Issuing entity: GS1

Classification

Risk category: Class I
Applicable legislation: MDR [Regulation (EU) 2017/745 on medical devices]
Status: On the market

Device details

Quantity: 1
Additional product description: —
Additional information URL: No additional information URL provided by the manufacturer.
Clinical sizes: No clinical sizes registered for this device.

EMDN nomenclature code(s)

L091001INSTRUMENTS FOR INSERTION AND EXTRACTION OF MATERIALS FOR OSTEOSYNTHESIS, REUSABLE

Compliance flags

Safety

Sterile

Single use

Contains latex

Reprocessed single-use

Direct marking

Substances

CMR substance

Endocrine disruptor

Regulatory

Annex XVI applicable

Sterilization

Lifecycle

New device

UDI-PI traceability

Batch number
Expiration date
Manufacturing date
Serial number
Software identification